Secondary Logo

Journal Logo

Erratum

Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock: Erratum

doi: 10.1097/CCE.0000000000000609
  • Open

In the article in the July 2021 compendium, the following disclosure was missing:

Dr. Schmid-Schonbein owns stock in Palisade Bio, a company to develop shock treatments.

REFERENCE

Mazor R, Dos Santos F, Joyce B, et al.: Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock. Crit Care Explor 2021; 3:e0469
    Copyright © 2021 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.